טוען...
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
INTRODUCTION: Therapeutic options for diffuse malignant peritoneal mesothelioma (DMPM) are limited to surgery and locoregional chemotherapy. Despite improvements in survival rates, patients eventually succumb to disease progression. We investigated splicing deregulation both as molecular prognostic...
שמור ב:
| הוצא לאור ב: | EBioMedicine |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355829/ https://ncbi.nlm.nih.gov/pubmed/30581150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.12.025 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|